A red herring in vascular calcification: 'Nanobacteria' are protein-mineral complexes involved in biomineralization

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3436-3439

  Schlieper, Georg ^a   Krüger, Thilo ^a   Heiss, Alexander ^a   Jahnen Dechent, Willi ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

biomineralization; nanobacteria; nanoparticles; vascular calcification

Indexed keywords

CALCIUM ION; MINERAL; NANOPARTICLE; NUCLEIC ACID; PHOSPHATE; PROTEIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM; BIOMINERALIZATION; BLOOD VESSEL CALCIFICATION; BONE METABOLISM; DISEASE MODEL; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY POLYCYSTIC DISEASE; MORBIDITY; MORTALITY; NANOBACTERIUM; NONHUMAN; PRIORITY JOURNAL;

BACTERIA; BACTERIAL INFECTIONS; CALCIFYING NANOPARTICLES; HUMANS; MINERALS; VASCULAR CALCIFICATION;

EID: 80155136209     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr521     Document Type: Article

References (37)

1. Schinke T, McKee MD, Karsenty G. Extracellular matrix calcification: Where is the action? Nat Genet 1999; 21: 150-151
2. Jahnen-Dechent W, Heiss A, Schafer C et al. Fetuin-a regulation of calcified matrix metabolism. Circ Res 2011; 108: 1494-1509
3. Murshed M, Harmey D, Millan JL et al. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 2005; 19: 1093-1104
4. Folk RL. SEM imaging of bacteria and nannobacteria in carbonate sediments and rocks. J Sediment Petrol 1993; 63: 990-999
5. McKay DS, Gibson EK Jr, Thomas-Keprta KL et al. Search for past life on Mars: Possible relic biogenic activity in martian meteorite ALH84001. Science 1996; 273: 924-930
6. Kajander EO, Ciftcioglu N. Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A. 1998; 95: 8274-8279
7. Ciftcioglu N, Bjorklund M, Kuorikoski K et al. Nanobacteria: An infectious cause for kidney stone formation. Kidney Int 1999; 56: 1893-1898
8. Sedivy R, Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 2003; 111: 951-954
9. Hjelle JT, Miller-Hjelle MA, Poxton IR et al. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 2000; 57: 2360-2374
10. Miller VM, Rodgers G, Charlesworth JA et al. Evidence of nanobacterial- like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004; 287: H1115-H1124
11. Cisar JO, Xu DQ, Thompson J et al. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A. 2000; 97: 11511-11515
12. Martel J, Young JD. Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci U S A. 2008; 105: 5549-5554
13. Young JD, Martel J, Young D et al. Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS One 2009; 4: E5421
14. Wu CY, Martel J, Young D et al. Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: Demonstration of a dual inhibition-seeding concept. PLoS One 2009; 4: E8058
15. Raoult D, Drancourt M, Azza S et al. Nanobacteria are mineralo fetuin complexes. PLoS Pathog 2008; 4: E41
16. Young JD, Martel J, Young L et al. Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 2009; 4: E4417
17. Ciftcioglu N, McKay DS. Pathological calcification and replicating calcifying-nanoparticles: General approach and correlation. Pediatr Res 2010; 67: 490-499
18. Schlieper G, Westenfeld R, Brandenburg V et al. Inhibitors of calcification in blood and urine. Semin Dial 2007; 20: 113-121
19. Genge BR, Wu LN, Wuthier RE. In vitro modeling of matrix vesicle nucleation: Synergistic stimulation of mineral formation by annexin A5 and phosphatidylserine. J Biol Chem 2007; 282: 26035-26045
20. Price PA, Nguyen TM, Williamson MK. Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 2003; 278: 22153-22160
21. Heiss A, DuChesne A, Denecke B et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 2003; 278: 13333-13341
22. Aizenberg J, Weiner S, Addadi L. Coexistence of amorphous and crystalline calcium carbonate in skeletal tissues. Connect Tissue Res 2003; 44 (Suppl 1): 20-25
23. Mahamid J, Aichmayer B, Shimoni E et al. Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci U S A. 2010; 107: 6316-6321
24. Sandin K, Kloo L, Nevsten P et al. Formation of carbonated apatite particles from a supersaturated inorganic blood serum model. J Mater Sci Mater Med 2009; 20: 1677-1687
25. Robinson C. Self-oriented assembly of nano-apatite particles: A subunit mechanism for building biological mineral crystals. J Dent Res 2007; 86: 677-679
26. Schlieper G, Aretz A, Verberckmoes SC et al. Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol 2010; 21: 689-696
27. Becker A, Epple M, Muller KM et al. A comparative study of clinically well-characterized human atherosclerotic plaques with histological, chemical, and ultrastructural methods. J Inorg Biochem 2004; 98: 2032-2038
28. Neven E, De Schutter TM, De Broe ME et al. Cell biological and physicochemical aspects of arterial calcification. Kidney Int 2011; 79: 1166-1177
29. Price PA, Williamson MK, Nguyen TM et al. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 2004; 279: 1594-1600
30. Hamano T, Matsui I, Mikami S et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 2010; 21: 1998-2007
31. Reynolds JL, Skepper JN, McNair R et al. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005; 16: 2920-2930
32. Jahnen-Dechent W, Schafer C, Ketteler M et al. Mineral chaperones: A role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008; 86: 379-389
33. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874
34. Jahnen-Dechent W. Lotś wifeś problem revisted: How we prevent pathological calcification. In: Baeuerlein E, (ed). Biomineralization Progress in Biology, Molecular Biology and Application. Weinheim: Wiley-VCH; 2004:245-267
35. Heiss A, Pipich V, Jahnen-Dechent W et al. Fetuin-A is a mineral carrier protein: Small angle neutron scattering provides new insight on fetuin-a controlled calcification inhibition. Biophys J 2010; 99: 3986-3995
36. Wald J, Wiese S, Eckert T et al. Structure and stability of calcium phosphate - fetuin-A colloids probed by time-resolved dynamic light scattering. Soft Matter 2011; 7: 2869-2874
37. Olde Loohuis KM, Jahnen-Dechent W, van DW. The case: Milky ascites is not always chylous. Kidney Int 2010; 77: 77-78